Quantcast

Sunflower State News

Thursday, November 21, 2024

FDA conducted third highest number of inspections on Biologics companies in Kansas during Q2 2023

Webp btx5fmm7r5ptppa0ig00pmlbqqx5

Vid Desai FDA’s Chief Information Officer | Official Website

Vid Desai FDA’s Chief Information Officer | Official Website

In the second quarter of 2023, two Biologics companies received two FDA inspections in Kansas, according to the U.S. Food and Drug Administration (FDA).

This was the third highest number of inspections per type of company made by the FDA in Kansas, equalling 6.3% of all inspections in the second quarter of 2023.

Of all the Kansas companies involved in the Biologics sector, Lisa A. Clough, M.D. received the most citations from the FDA in the second quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Kansas During Q2 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring21--
Compliance: Devices11--
Foodborne Biological Hazards101--
Monitoring of Marketed Animal Drugs, Feed, and Devices141--
Postmarket Assurance: Devices2----
Tobacco Post-Market Activities1----

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS